Table 1: Demographical and clinical characteristics of patients.

Overall (n = 97) CoreValve (n = 56) Edwards SAPIEN (n = 41 ) p
Baseline characteristics
Male, n (%) 50 (51%) 31 (5.4%) 19 (46.3%) 0.38
Age (years) 74.6 ± 7.4 73.1 ± 7.6 76.7 ± 6.6 0.019
Body mass index (kg/m2) 25.5 ± 2.5 25.1 ± 2.2 26.0 ± 2.7 26.0 ± 2.7
NYHA 0.196
NYHA 2, n (%) 14 (14.4%) 5 (8.9%) 9 (22.0%)
NYHA 3, n (%) 55 (56.7%) 34 (60.7%) 21 (51.2%)
NYHA 4, n (%) 28 (28.9%) 17 (30.4%) 11 (26.8%)
Risk assessment
Logistic EuroScore (%) 23.5 ± 4.5 24.7 ± 5.0 21.8 ± 3.1 0.002
STS score (%) 10.5 ± 2.0 10.8 ± 2.0 10.1 ± 2.1 0.065
Comorbidities
CAD, n (%) 48 (49.5%) 26 (46.4%) 22 (53.7%) 0.618
Atrial fibrillation, n (%) 35 (36.1%) 21 (37.5%) 14 (34.1%) 0.9
COPD, n (%) 30 (30.9%) 24 (42.9%) 6 (14.6%) 0.006
Diabetes mellitus, n (%) 25 (25.8%) 13 (23.2%) 12 (29.2%) 0.661
PAD, n (%) 28 (28.9%) 16 (28.6%) 12 (29.3%) 0.95
Hypertension, n (%) 57 (58.8%) 35 (62.5%) 22 (53.7%) 0.506
Smoker, n (%) 29 (29.9%) 21 (37.5%) 22 (53.7%) 0.92
Previous stroke, n (%) 11 (11.3%) 7 (12.5%) 4 (9.8%) 0.672
Previous CABG, n (%) 18 (18.6%) 7 (12.5%) 6 (14.6%) 0.558
Echocardiographic variables
PAPs (mmHg) 45.7 ± 11.2 49.6 ± 12.4 40.3 ± 6.2 0.001
Concomitant AR > 2, n (%) 7 (7.2%) 4 (7.1%) 3 (7.2%) 0.974
Concomitant MR > 2, n (%) 23 (23.7%) 15 (26.8%) 8 (19.5%) 0.405
Laboratory parameters
Haemoglobin (mg/dl) 13.0 ± 1.7 13.2 ± 1.9 12.6 ± 1.4 0.064
Serum creatinine (mg/dl) 1.3 ± 0.5 1.3 ± 0.5 1.4 ± 0.4 0.474
WBC (×103 cells/μL) 8.5 ± 2.4 8.2 ± 2.3 8.8 ± 2.6 0.27
Neutrophil cell count 6.1 ± 2.0 5.5 ± 2.1 7.0 ± 1.6 0.001
Lymphocyte cell count 2.2 ± 0.9 2.0 ± 0.8 2.4 ± 0.9 0.013

NYHA: New York Heart Association; CAD: Coronary Artery Disease; COPD: Chronic Obstructive Pulmonary Disease; PAD: Peripheral Arterial Disease; CABG: Coronary Artery Bypass Grafting; PAPs: Pulmonary Arterial Pressure-Systole; AR: Aortic Regurgitation; MR: Mitral Regurgitation; WBC: White Blood Cell Count.